ENVB
Enveric Biosciences Inc
3월 13일 4:00 PM ET (한국 3/14 05:00)
$1.90
-0.02 ▼ -1.04%
🌙 3월 13일 7:22 PM ET (한국 3/14 08:22)
$1.89
-0.01 ▼ -0.53%
| Index | - | P/E | - | EPS (ttm) | -94.85 | Insider Own | 19.47% | Shs Outstand | 0.00B | Perf Week | -2.31% |
| Market Cap | 0.00B | Forward P/E | - | EPS next Y | - | Insider Trans | - | Shs Float | 0.00B | Perf Month | -9.95% |
| Enterprise Value | -0.00B | PEG | - | EPS next Q | - | Inst Own | 22.75% | Short Float | 10.57% | Perf Quarter | -81.61% |
| Income | -0.01B | P/S | - | EPS this Y | - | Inst Trans | 5.34% | Short Ratio | 0.31 | Perf Half Y | -84.09% |
| Sales | 0.00B | P/B | 0.28 | EPS next 5Y | - | ROA | -212.68% | Short Interest | 0.12M | Perf YTD | -47.66% |
| Book/sh | 6.67 | P/C | 0.7 | EPS past 3/5Y | 76.95% 57.47% | ROE | -262.78% | 52W High | -91.44% ($22.20) | Perf Year | -90.35% |
| Cash/sh | 2.71 | P/FCF | - | Sales past 3/5Y | - | ROIC | -325.39% | 52W Low | 4.4% ($1.82) | Perf 3Y | -99.44% |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | 79.45% | Gross Margin | - | Volatility(W/M) | 5.83% 8.29% | Perf 5Y | -99.99% |
| Dividend TTM | - | EV/Sales | - | Sales Y/Y TTM | - | Oper. Margin | - | ATR (14) | 0.21 | Perf 10Y | -100% |
| Dividend Ex-Date | - | Quick Ratio | 4.56 | EPS Q/Q | 74.91% | Profit Margin | - | RSI (14) | 32.91 | Recom | 1 |
| Dividend Gr. 3/5Y | - | Current Ratio | 4.56 | Sales Q/Q | - | SMA20 | -10.62% ($2.13) | Beta | 0.32 | Target Price | $1800 |
| Payout | - | Debt/Eq | 0 | Earnings | 11000000 | SMA50 | -35.22% ($2.93) | Rel Volume | 0.06 | Prev Close | $1.92 |
| Employees | 5 | LT Debt/Eq | 0 | EPS/Sales Surpr. | - | SMA200 | -78.2% ($8.72) | Avg Volume(3M) | 0.38M | Price | $1.9 |
| IPO | 1995/8/22 | Option/Short | No/Yes | Trades | 222 | Volume | 22,530 | Change | -1.04% |
뉴스 로딩 중...